Aladdin Healthcare Technologies SE
ALDNF · OTC
6/30/2021 | 12/31/2020 | 6/30/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.07 | 0.00 |
| FCF Yield | 0.00% | -5.50% | -5.06% | -9.41% |
| EV / EBITDA | 0.00 | -13.39 | -12.96 | -120.24 |
| Quality | ||||
| ROIC | 0.00% | 490.92% | 107.58% | 419.46% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.48 | 0.48 | 0.53 | 0.53 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | 443,422.01% | 558,702.71% | 558,702.71% |
| Free Cash Flow Growth | 0.00% | 0.00% | 60.74% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | -3.77 | -2.49 | -16.70 |
| Interest Coverage | 0.00 | -11.40 | -11.40 | -23.70 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -2,454.03 | -1,917.34 | -29,179.49 |